Next Article in Journal
Motivation to Consent and Adhere to the FORT Randomized Controlled Trial
Next Article in Special Issue
Innovations in the Management of Vaginal Cancer
Previous Article in Journal
DTI Abnormalities Related to Glioblastoma: A Prospective Comparative Study with Metastasis and Healthy Subjects
Previous Article in Special Issue
Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer
Review

New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review

1
Department of Oncology, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
2
Department of Medical Oncology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Curr. Oncol. 2022, 29(4), 2835-2847; https://doi.org/10.3390/curroncol29040231
Received: 31 January 2022 / Revised: 19 March 2022 / Accepted: 6 April 2022 / Published: 17 April 2022
(This article belongs to the Special Issue New Frontiers in Treatment for Gynecologic Cancers)
This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clinical Oncology (ASCO) Annual Meeting, the European Society for Medical Oncology (ESMO) Congress and the Society of Gynecologic Oncology (SGO) Annual Meeting). Despite the underlying existence of the COVID-19 pandemic, the last year has been notable in terms of research, with significant and promising advances in gynecological malignancies. Several major studies reporting the effects of innovative therapies for patients with cervical, endometrial, and ovarian cancers might change the medical practice in the future. View Full-Text
Keywords: cervical cancer; endometrial cancer; ovarian cancer; 2021 update; novel targeted therapies; immunotherapy cervical cancer; endometrial cancer; ovarian cancer; 2021 update; novel targeted therapies; immunotherapy
MDPI and ACS Style

Gheorghe, A.S.; Dumitrescu, E.A.; Komporaly, I.A.; Mihăilă, R.I.; Lungulescu, C.V.; Stănculeanu, D.L. New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review. Curr. Oncol. 2022, 29, 2835-2847. https://doi.org/10.3390/curroncol29040231

AMA Style

Gheorghe AS, Dumitrescu EA, Komporaly IA, Mihăilă RI, Lungulescu CV, Stănculeanu DL. New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review. Current Oncology. 2022; 29(4):2835-2847. https://doi.org/10.3390/curroncol29040231

Chicago/Turabian Style

Gheorghe, Adelina S., Elena A. Dumitrescu, Isabela A. Komporaly, Raluca I. Mihăilă, Cristian V. Lungulescu, and Dana L. Stănculeanu. 2022. "New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review" Current Oncology 29, no. 4: 2835-2847. https://doi.org/10.3390/curroncol29040231

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop